| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5685267 | American Journal of Kidney Diseases | 2017 | 9 Pages |
Abstract
There was no evidence that low zinc, selenium, or manganese concentrations exist in most contemporary Canadian hemodialysis patients. Some patients have excessive plasma arsenic and mercury concentrations, and excessive lead concentrations were common. These findings require further investigation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Marcello MD, SM, Natasha MMath, PStat, Aminu MD, PhD, Catherine J. RD, PhD, John S. MD, MS, Brenda R. MD, PhD, Daniel T. MD, Kailash MBBS, Scott W. MD, MSc, Braden J. MD, MSc, Ravi MD, MPH, David PhD,